sfdsd

Vaxart to delay COVID-19 clinical trials in portfolio reorganizationMar. 15, 2023 4:33 PM ETVaxart, Inc. (VXRT)By: Dulan Lokuwithana, SA News Editor5 CommentsQuarterly ResultsAajan Issuing its Q4 2022 financials on Wednesday, vaccine developer Vaxart (NASDAQ:VXRT) announced a portfolio reorganization to prioritize its oral norovirus vaccine progr...